Post-operative Medium Chain Triglyceride Diet May Reduce Hospital Stay Following Lung Resection

Recruiting N/A Interventional Study
Thoracic Neoplasms
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
210 (estimated)
Sponsor
Chinese University of Hong Kong · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Lung resection, a critical treatment for various thoracic diseases, including lung cancer, often necessitates prolonged hospitalization due to rare but severe postoperative complications such as chyle leaks, with an occurrence of 0.25%-3%, prolonging chest drainage, and delaying recovery. Therefore, effective postoperative care is essential for optimizing outcomes, reducing complications, and expe…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: General Inclusion Criteria for All procedures: 1. Age between 18 - 80 years 2. Body mass index \<35 kg/m2 3. Suitable for minimally invasive surgery 4. Willingness to participate as demonstrated by giving informed consent Project-specific Criteria: 1\. Patients performed lobe…
Contacts

Calvin Sze Hang Ng

+852 3505 2618

calvinng@surgery.cuhk.edu.hk

CONTACT